Oral Answers to Questions

Debate between Paul Beresford and Lord Cameron of Chipping Norton

Wednesday 11th May 2011 Commons Chamber

[Sir Paul Beresford (Mole Valley) (Con)]

Q2. I have a slightly calmer question, Mr Speaker. I am sure that the Prime Minister is aware that the fatal and incurable human brain disease variant Creutzfeldt-Jakob disease is transferred through prions, blood products and surgical instruments. Recently, Professor Collinge and others at the Medical Research Council prion unit have produced an effective prion-deactivation instrument soak and a blood test for variant CJD, both of which could and should protect the public. Unfortunately, there has been a small financial hiccup in progressing those breakthroughs. Does the Prime Minister accept the importance of preventing this despicable disease, particularly for future generations, and will he meet me and Professor Collinge to discuss potential progress?

[The Prime Minister]

My hon. Friend raises an important point about a very dangerous disease and I would certainly be happy to arrange a meeting, probably between him and Professor Sally Davies, the chief medical officer, to discuss this. He will know that there have been various research studies into the impact of variant CJD on the population. We do not yet have all the answers that we need. Since 1990, there has been funding of the national CJD research and surveillance unit to the tune of £18 million, and through the Medical Research Council we have committed to providing £32 million to the national prion unit between 2010 and 2014. That should be the money that gets the answers that he so badly wants.